ATE541583T1 - Enzym-enthaltendes präparat, verfahren zur herstellung und verwendung - Google Patents

Enzym-enthaltendes präparat, verfahren zur herstellung und verwendung

Info

Publication number
ATE541583T1
ATE541583T1 AT03730062T AT03730062T ATE541583T1 AT E541583 T1 ATE541583 T1 AT E541583T1 AT 03730062 T AT03730062 T AT 03730062T AT 03730062 T AT03730062 T AT 03730062T AT E541583 T1 ATE541583 T1 AT E541583T1
Authority
AT
Austria
Prior art keywords
preparation
composition
enzyme
relates
present
Prior art date
Application number
AT03730062T
Other languages
English (en)
Inventor
Ingo Haeberlein
Rainer Guggenberger
Wolfgang Weinmann
Oliver Kappler
Original Assignee
3M Espe Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Espe Ag filed Critical 3M Espe Ag
Application granted granted Critical
Publication of ATE541583T1 publication Critical patent/ATE541583T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886Metalloendopeptidases (3.4.24), e.g. collagenase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
AT03730062T 2002-08-15 2003-05-16 Enzym-enthaltendes präparat, verfahren zur herstellung und verwendung ATE541583T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10237317A DE10237317B4 (de) 2002-08-15 2002-08-15 Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP2003/005183 WO2004017988A1 (en) 2002-08-15 2003-05-16 Enzyme containing composition, process of producing said composition and its use

Publications (1)

Publication Number Publication Date
ATE541583T1 true ATE541583T1 (de) 2012-02-15

Family

ID=31501753

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03730062T ATE541583T1 (de) 2002-08-15 2003-05-16 Enzym-enthaltendes präparat, verfahren zur herstellung und verwendung

Country Status (9)

Country Link
US (2) US20060115436A1 (de)
EP (2) EP1530481B1 (de)
JP (2) JP4571859B2 (de)
CN (2) CN101810856B (de)
AT (1) ATE541583T1 (de)
AU (2) AU2003240667C1 (de)
CA (1) CA2490721A1 (de)
DE (1) DE10237317B4 (de)
WO (1) WO2004017988A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10237317B4 (de) 2002-08-15 2010-04-08 3M Espe Ag Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
DE602005011933D1 (de) 2004-02-27 2009-02-05 3M Espe Ag Dosiersystem
EP1600141B1 (de) 2004-05-24 2013-04-17 3M Deutschland GmbH Zusammensetzungen mit kollagenolytisch aktivem Enzym zur Behandlung von Karies
EP1634948A1 (de) 2004-09-10 2006-03-15 Basf Aktiengesellschaft Mittel und Verfahren zur Vorbeugung und/oder Behandlung von Karies
EP1754464A1 (de) 2005-08-17 2007-02-21 3M Innovative Properties Company Enzym-haltige Zusammensetzung für den dentalen Gebrauch
EP1844727A1 (de) 2006-04-12 2007-10-17 3M Innovative Properties Company Zahnärztliches Instrument zur ausschliesslichen Beseitigung von kariösem Dentin
CN104814983A (zh) 2006-12-19 2015-08-05 巴斯夫欧洲公司 用于预防和/或治疗变形链球菌群引起的龋的用途和方法
EP2139979B1 (de) 2007-03-27 2015-02-25 Novozymes A/S Stabile enzymlösungen und herstellungsverfahren
ES2645062T3 (es) * 2008-02-08 2017-12-04 Prothera, Inc. Inhibición y tratamiento de biopelículas gastrointestinales
JP5833576B2 (ja) 2010-02-25 2015-12-16 ノボザイムス アクティーゼルスカブ リゾチームの変異体及びそれをコードするポリヌクレオチド
EP2616483A1 (de) 2010-09-16 2013-07-24 Novozymes A/S Lysozyme
DK2782592T3 (en) 2011-11-25 2017-06-19 Novozymes As Polypeptides with lysozyme activity and polynucleotides encoding them
CA2860916A1 (en) 2012-01-23 2013-08-01 Morphosys Ag Use of lysozyme as a tag
CN106604930B (zh) * 2014-05-30 2021-10-29 新英格兰生物实验室公司 去糖基化试剂和方法
WO2017140807A1 (en) 2016-02-16 2017-08-24 Monaghan Mushrooms Group Fungal polypeptides having lysozyme activity
US10451599B2 (en) * 2016-09-02 2019-10-22 Zepto Life Technology, LLC Methods of isolating and detecting metal ions from proteins
CN110621779B (zh) 2017-05-12 2024-05-14 诺维信公司 具有溶菌酶活性的多肽、编码其的多核苷酸以及其用途和组合物
US11571367B2 (en) * 2018-04-05 2023-02-07 Terrell F. Pannkuk Composition and method for endodontic debridement
WO2024121324A1 (en) 2022-12-08 2024-06-13 Novozymes A/S Polypeptide having lysozyme activity and polynucleotides encoding same

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1265468A (en) * 1917-09-18 1918-05-07 Chresten Torben Madsen Level.
DE1467951A1 (de) * 1963-09-04 1969-02-13 Iptor Pharmazeutische Praepara Proteolytische Enzyme enthaltende Zahnreinigungsmittel
NL148236B (nl) * 1967-07-28 1976-01-15 Merck & Co Inc Werkwijze voor het bereiden van enzym bevattende tand- en mondverzorgingsmiddelen en aldus verkregen gevormde produkten.
BE755331A (fr) * 1969-09-01 1971-02-01 Blendax Werke Schneider Co Produits de soins buccaux et dentaires
DE2309440A1 (de) * 1973-02-26 1974-09-05 Katz Verfahren zum isolieren von lysozym
JPS56106593A (en) 1980-01-24 1981-08-24 Dainippon Pharmaceut Co Ltd Alkali protease m3
JPS57142910A (en) 1981-02-28 1982-09-03 Sankin Kogyo Kk Water-soluble solid agent for cleaning artificial denture
US4355022A (en) 1981-07-01 1982-10-19 Interon, Inc. Method of dental treatment
JPS58148828A (ja) * 1982-02-27 1983-09-05 Advance Res & Dev Co Ltd 歯根管処理剤並びに同処理用キツト
WO1984002653A1 (fr) * 1983-01-05 1984-07-19 Pasteur Institut Preparation a activite collagenolytique ayant une activite elevee et compositions pharmaceutiques la contenant
US4693888A (en) * 1983-08-11 1987-09-15 Lion Corporation Caries-preventive composition
JPH024710A (ja) 1988-06-23 1990-01-09 Nippon Soda Co Ltd 感染根管及び根尖性歯周組織炎治療用製剤
FR2651433B1 (fr) * 1989-09-07 1994-01-14 Dominique Dana Complexe enzymatique a activite sur le tartre et la carie dentaire.
GB8926904D0 (en) * 1989-11-28 1990-01-17 Unilever Plc Thickening system
JP2566676B2 (ja) 1990-03-28 1996-12-25 株式会社クラレ 歯科用組成物
JPH05503947A (ja) 1990-12-05 1993-06-24 ワーナー―ランバート・コンパニー 義歯用の酵素含有クレンザー
GB9207280D0 (en) 1992-04-02 1992-05-13 Unilever Plc Skin care method and composition
SE9201628D0 (sv) 1992-05-22 1992-05-22 Phairson Medical Ab Pharmaceutical composition
JP3144102B2 (ja) 1992-12-08 2001-03-12 三菱マテリアル株式会社 歯牙根管消毒剤
US5386024A (en) * 1993-02-10 1995-01-31 Gen-Probe Incorporated Method to prepare nucleic acids from a biological sample using low pH and acid protease
JPH0769854A (ja) * 1993-09-02 1995-03-14 Lion Corp 義歯洗浄剤
JP3396934B2 (ja) * 1993-12-01 2003-04-14 ライオン株式会社 義歯洗浄剤
RU2083215C1 (ru) 1994-05-11 1997-07-10 Петр Григорьевич Сторожук Средство для лечения секреторной недостаточности желудка преимущественно у новорожденных детей - пепсирен
EP0776163A4 (de) 1994-09-09 1999-11-24 Univ Maryland Bakteriophagen kodierende enzyme zur behandlung und vorbeugung von zahnkaries und periodontalen erkrankungen
US5670132A (en) * 1994-09-20 1997-09-23 Immunomedics, Inc. Modified radioantibody fragments for reduced renal uptake
KR19980703322A (ko) * 1995-03-28 1998-10-15 슈타르 피아 엠. 구강보호 조성물
US5625341A (en) 1995-08-31 1997-04-29 Sensormatic Electronics Corporation Multi-bit EAS marker powered by interrogation signal in the eight MHz band
CN1215310A (zh) 1996-03-06 1999-04-28 诺沃挪第克公司 一种杀死或抑制微生物细胞的方法
CN1216463A (zh) 1996-04-16 1999-05-12 诺沃挪第克公司 祛除齿斑的组合物
SE507437C2 (sv) 1996-11-14 1998-06-08 Medi Team Dentalutveckling I G Preparat för användning vid kemisk-mekanisk behandling av kariesangrepp och förfarande för framställning av preparatet
US6287550B1 (en) * 1996-12-17 2001-09-11 The Procter & Gamble Company Animal care system and litter with reduced malodor impression
US6100080A (en) 1996-12-18 2000-08-08 Novo Nordisk A/S Method for enzymatic treatment of biofilm
WO1998034957A1 (en) * 1997-02-11 1998-08-13 Immunomedics, Inc. STIMULATION OF AN IMMUNE RESPONSE WITH ANTIBODIES LABELED WITH THE α-GALACTOSYL EPITOPE
EP0964909A1 (de) * 1997-03-07 1999-12-22 The Procter & Gamble Company Reinigungszusammensetzungen enthaltend alkalisches xylanabbauendes enzym und nichtpflanzliche zellwände abbauendes enzym
MXPA00000360A (es) * 1997-07-09 2001-08-01 Alfred Busch Composiciones de limpieza que comprenden una oxigenasa especif
DE29714246U1 (de) 1997-08-08 1998-12-10 THERA Patent GmbH & Co. KG Gesellschaft für industrielle Schutzrechte, 82229 Seefeld Vorrichtung zum Lagern und Auftragen einer fließfähigen Substanz
BR9915155B1 (pt) 1998-11-09 2012-03-06 mÉtodos para matar ou inibir cÉlulas microbianas, para inibir microorganismos presentes na lavanderia, para preservar um produto cosmÉtico e para limpar, desinfetar ou inibir o desenvolvimento microbiano em uma superfÍcie dura, composiÇÕes detergente e enzimÁtica antimicrobiana, e, uso de uma composiÇço.
US6521215B2 (en) * 1999-05-28 2003-02-18 Devin Okay Compositions and methods for tooth treatment
JP4175746B2 (ja) * 1999-08-30 2008-11-05 独立行政法人科学技術振興機構 新規な耐熱性コラーゲン分解酵素、前記酵素を産生する新規な微生物および前記酵素の製造方法
DE19955746B4 (de) * 1999-11-19 2004-01-29 3M Espe Ag Oberflächenbehandlungsmittel für Hartgewebe und Verwendung von die Enzymaktivität begrenzenden Mitteln zu dessen Herstellung
DE10034647C1 (de) 2000-07-14 2002-04-04 3M Espe Ag Verfahren zur Durchführung einer Speichelanalyse
JP2002078489A (ja) 2000-09-04 2002-03-19 Daiwa Kasei Kk セリン残基が活性発現に関与する新規酸性プロテアーゼ
DE10056212B4 (de) * 2000-11-13 2005-08-18 3M Espe Ag Vorrichtung zum Lagern und Ausbringen von fließfähigen Zusammensetzungen, Verfahren zur Herstellung und Verwendung der Vorrichtung
US7402416B2 (en) 2002-05-10 2008-07-22 Colgate-Palmolive Company Antibacterial dentifrice exhibiting antiplaque and breath freshening properties
AU2003279247A1 (en) 2002-06-21 2004-01-06 New Horizons Diagnostics Corporation The use of bacterial phage associated lysing proteins for treating bacterial dental caries
DE10237317B4 (de) 2002-08-15 2010-04-08 3M Espe Ag Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
AU2003285325A1 (en) 2002-11-22 2004-06-18 Unilever Plc Oral compositions comprising salts of alkyl hydroxybenzoates
US20040120901A1 (en) 2002-12-20 2004-06-24 Dong Wu Dental compositions including enzymes and methods
EP1600141B1 (de) 2004-05-24 2013-04-17 3M Deutschland GmbH Zusammensetzungen mit kollagenolytisch aktivem Enzym zur Behandlung von Karies
EP1754464A1 (de) 2005-08-17 2007-02-21 3M Innovative Properties Company Enzym-haltige Zusammensetzung für den dentalen Gebrauch

Also Published As

Publication number Publication date
EP1530481B1 (de) 2012-01-18
CN101810856B (zh) 2015-05-13
CN101810856A (zh) 2010-08-25
US20060115436A1 (en) 2006-06-01
US9050332B2 (en) 2015-06-09
EP2314307B1 (de) 2014-03-12
DE10237317A1 (de) 2004-03-11
EP2314307A1 (de) 2011-04-27
AU2010201297A1 (en) 2010-04-22
AU2003240667C1 (en) 2010-07-15
AU2010201297B2 (en) 2012-12-13
CN1674930A (zh) 2005-09-28
JP2010090164A (ja) 2010-04-22
WO2004017988A1 (en) 2004-03-04
JP2006501225A (ja) 2006-01-12
US20080213196A1 (en) 2008-09-04
JP5087611B2 (ja) 2012-12-05
DE10237317B4 (de) 2010-04-08
AU2003240667A1 (en) 2004-03-11
CA2490721A1 (en) 2004-03-04
EP1530481A1 (de) 2005-05-18
JP4571859B2 (ja) 2010-10-27

Similar Documents

Publication Publication Date Title
ATE541583T1 (de) Enzym-enthaltendes präparat, verfahren zur herstellung und verwendung
DE60311820D1 (de) Neue verwendung von pyrimidin- oder triazin-2-carbonsäurenitrilen zur behandlung von krankheiten, die mit cysteinproteaseaktivität assoziiert sind, und neue pyridimidin-2-carbonsäurenitrilderivate
DE50002450D1 (de) Enzyme zur behandlung von diabetes mellitus typ i
DE69725354D1 (de) Intermediate zur Herstellung von Thrombininhibitoren als Anticoagulantien
GB0228410D0 (en) Novel Compounds
NO302474B1 (no) Sakarinderivater, farmasöytisk sammensetning og anvendelse derav
DE60236814D1 (de) 3-alkyl-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthole und 3,3'-dialkyl-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthole, sowie verfahren zur ihrer herstellung
BR0214035A (pt) Composto
HK1071131A1 (en) Small molecule inhibitors of rotamase enzyme activity
TW225532B (de)
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
ATE186305T1 (de) Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung
ATE342964T1 (de) Rekombinante alpha-l-iduronisase, deren herstellungs- und aufreinigungsverfahren, und behandlung von durch diese hervorgerufene mangelerkrankungen
DE60134995D1 (de) Verfahren und zusammensetzungen, die eine stearoyl-coa desuturase-hscd5 verwenden
ATE527261T1 (de) 7-aryl-3,9-diazabicycloä3.3.1ünon-6-en-derivate und ihre verwendung als renin-inhibitoren zur behandlung von bluthochdruck, herz-kreislauf- erkrankungen und nierenkrankheiten
ATE293976T1 (de) Verbindungen enthaltend s-tofisopam sowie verwendung dieser verbindungen zur herstellung eines medikamentes zur behandlung oder prophylaxe von krämpfen und anfällen
AU2003243097A1 (en) Novel compounds
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
GB0328900D0 (en) Novel compounds
DE60313803D1 (de) Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen
WO2004024077A3 (en) Novel composition and methods for the treatment of psoriasis
DE60227008D1 (de) Neue thiophenacylhydrazinoderivate, verfahren zu deren herstellung, deren verwendung als arzneimittel, pharmazeutische zusammensetzungen und neue anwendungen
ATE121626T1 (de) Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut.
DE59914749D1 (de) Ustilipide, verfahren zu deren herstellung sowie deren verwendung
DE60233353D1 (de) Verfahren zur behandlung von halitose